Acute Erythroblastic Leukemia

Search Trials
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Mar 30, 2018
First Changed:
Feb 28, 2013
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
mitoxantrone hydrochloridecytarabineperipheral blood stem cell transplantationlaboratory biomarker analysis
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Aug 20, 2015
First Changed:
Dec 15, 2010
Disease(s):
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Intervention(s):
AzacitidineEtoposideLaboratory Biomarker AnalysisMitoxantrone Hydrochloride
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Mar 28, 2022
First Changed:
Apr 15, 2008
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AzacitidineGemtuzumab Ozogamicin
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Status:
Completed
Last Changed:
Nov 1, 2018
First Changed:
Mar 3, 2011
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Caspofungin AcetateFluconazoleLaboratory Biomarker Analysis
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Status:
Completed
Last Changed:
Jan 28, 2022
First Changed:
Aug 29, 2006
Disease(s):
Childhood Acute Basophilic Leukemia
Intervention(s):
asparaginasedaunorubicin hydrochloridecytarabinethioguanineetoposidelaboratory biomarker analysis

Connect. Empower. Inspire.